Yale School of Management

Colloquium in Healthcare Leadership: Thursday Evening Series

Meet with the men and women who are leading efforts to improve the quality and efficiency of our healthcare system. Talk with thought leaders who craft policy at the state and federal level. Engage with life sciences entrepreneurs who are discovering and commercializing products that can extend and improve our lives. 

The Colloquium in Healthcare Leadership brings prominent leaders from public, private, and nonprofit healthcare organizations to campus for candid discussions. You will deepen your understanding of the major trends in healthcare as well as the challenges of being a leader in this space.

Thursday Evening Series - 6:30 PM, Beaumont Room, Sterling Hall of Medicine (2nd Floor), 333 Cedar Street


September 3, 2020 -- Introduction to Colloquium In Healthcare Leadership

  • Howard P. Forman, MD, MBA

    Director, YSPH Health Care Management Program

    Director, MD/MBA Program

    Professor of Radiology & Public Health (Health Policy)

    Professor in the Practice of Management

     Professor of Economics (joint by courtesy)

    Faculty Director, Executive MBA Program (Healthcare)

September 10, 2020

  • Jerome H. Kim, MD, Director General, The International Vaccine Institute

    Jerome H. Kim                                                                                       A person in a white room

Description automatically generated

    Director General

    International Vaccine Institute

    Jerome Kim, M.D., is the Director General of the International Vaccine Institute (IVI) and an international expert on the evaluation and development of vaccines. His depth and breadth of scientific experience span basic research through advanced clinical development. IVI’s oral cholera vaccine is used around the world to prevent this deadly diarrheal disease.  IVI’s typhoid conjugate vaccine, tech-transferred to SK bioscience and PT Bio Farma, is completing Phase III testing.  IVI is working on several different vaccines against COVID-19, including the clinical testing of Inovio’s DNA vaccine at Seoul National University Hospital and Genexine’s COVID-19 vaccine at Severance Hospital.

    Dr. Kim was Principal Deputy and Chief, Laboratory of Molecular Virology and Pathogenesis ,in the U.S. Military HIV Research Program (MHRP) and also served as the Project Manager for the HIV Vaccines and Advanced Concepts Evaluation Project Management Offices, U.S. Army Medical Materiel Development Activity, Fort Detrick, MD.  He led the Army's Phase III HIV vaccine trial (RV144) which was the first demonstration that an HIV vaccine could protect against infection, as well as subsequent studies that identified laboratory correlates and HIV sequence changes associated with vaccination.

    Dr. Kim has authored over 250 publications and received the John Maher Award for Research Excellence from the Uniformed Services University of the Health Sciences in 2013 and the Department of the Army R&D Award for Technical Excellence (2013).  Dr. Kim is also an Adjunct Professor of Medicine at the Uniformed Services University of the Health Sciences and at Yonsei University Graduate School of Public Health and a Fellow of the American College of Physicians and the Infectious Diseases Society of America. 

    He is a graduate of the University of Hawaii, with high honors in History and highest honors in Biology, and received his M.D. from Yale University School of Medicine.

September 17, 2020

  • Marna P. Borgstrom, MPH (’79), CEO and President, Yale New Haven Hospital and Yale New Haven Health Systems

    Marna P. Borgstrom

    Chief Executive Officer, Yale New Haven Health and Yale New Haven Hospital

    Marna Borgstrom has served as the Chief Executive Officer of Yale New Haven Hospital and Yale New Haven Health since 2005.  With revenues of $5.5B, Yale New Haven Health is the largest health system in the region and largest employer in Connecticut.  Marna began her career at Yale-New Haven Hospital over 40 years ago and served in a variety of staff and operational roles prior to her current positions. 

    Marna chairs the boards of the Healthcare Institute and the Coalition to Protect America’s Healthcare and is the past chair of Vizient, a Dallas, Texas-based health care company.  She serves on several other boards including the American Hospital Association, the Connecticut Hospital Association and New Haven Promise.  She is also a director of Cryolife in Atlanta, GA.

    Marna has been recognized for her commitment to community service and the health care field with numerous awards.  She also holds five honorary doctorate degrees.

    Marna received her undergraduate degree from Stanford University and was awarded a master’s of public health by the Yale University School of Epidemiology and Public Health. She is a lecturer at the Yale School of Epidemiology and Public Health, from which she received the Distinguished Alumni Award in 2018.

September 24, 2020

  • TBD

    Bio to come.

October 1st, 2020

  • Kevin B. Churchwell, MD, President/COO, Executive VP of Health Affairs, Boston Children's Hospital

    Kevin B. Churchwell, M.D.

    President and Chief Operating Officer

    Boston Children’s Hospital

    Dr. Churchwell brings over 25 years of experience as a clinician, researcher, hospital executive and administrator, as well as a valuable perspective in designing and implementing patient treatments. He currently serves as president and chief operating officer at Boston Children’s Hospital where he has been since August 2013.  He is also the Robert and Dan Smith Associate Professor of Anesthesia at Harvard Medical School. Previously, he served as chief executive officer of Nemours/Alfred I. DuPont Hospital for Children from 2010 to 2013 and as chief executive officer and executive director for the Monroe Carrell Jr. Children’s Hospital, part of the Vanderbilt University Medical Center, from 2007 to 2010. Dr. Churchwell has been a clinician and faculty member at Boston Children’s Hospital and Vanderbilt University Medical Center since 1993. Dr. Churchwell graduated with a B.S. in Biology from the Massachusetts Institute of Technology and received his M.D. from Vanderbilt Medical School.

October 8th, 2020

  • Eric Golding, MD, MBA ('05), Manager, Healthcare/Life Sciences Portfolio (Private Entity) (Former Vice President, Consonance Capital)

    Eric M. Golding, M.D., M.B.A.

    Dr. Golding is a physician by training with investment experience in both the private and public markets. He currently manages the healthcare/life sciences portfolio for a large family office. 

    Previously, he worked at Consonance Capital, a healthcare-only long/short public equity fund specializing in biopharmaceuticals, medical devices, diagnostics, and healthcare IT. Prior to joining Consonance, Dr. Golding worked in venture capital investing at F-Prime Capital Partners (formerly known as Fidelity Biosciences), a global venture capital firm specializing in biotechnology, pharmaceuticals, medical devices, diagnostics, and healthcare services/IT. While at F-Prime, Dr. Golding was a Board Observer for Iora Health, an IT-enabled healthcare services company focused on building and operating de novo primary care practices. He was also a Board Observer for Symbiomix Therapeutics, a company focused on developing therapeutics in the area of women’s health (acquired by Lupin). 

    Dr. Golding completed his training in Internal Medicine at Beth Israel Deaconess Medical Center, an affiliate of Harvard Medical School. He gained insight into the area of pharmaceutical regulation through an internship at the Food and Drug Administration in the Office of Regulatory Policy. He holds an MD from the Yale School of Medicine and an MBA from the Yale School of Management. He received a BA from the University of Pennsylvania, where he graduated summa cum laude.

October 29th, 2020

  • Sara Nayeem, MD, MBA ('06), Partner, NEA Venture Capital

    Sara Nayeem, M.D. is a Partner at New Enterprise Associates (NEA), a large diversified venture capital firm.  Sara joined NEA's healthcare team in 2009 and focuses on investments in biopharmaceutical companies. She serves on the boards of Centrexion, Cydan, Imara (IMRA), Tiburio, and a stealth targeted oncology company. She previously served on the boards of Vtesse (acquired by Sucampo), Mersana (MRSN), Therachon (acquired by Pfizer), and Complexa, and as a board observer for Loxo Oncology (LOXO, acquired by Lilly), Tesaro (TSRO, acquired by GlaxoSmithKline), Clementia (CMTA, acquired by Ipsen), Nightstar (NITE, acquired by Biogen), Ziarco (acquired by Novartis), Omthera (OMTH, acquired by AstraZeneca), Epizyme (EPZM), Millendo (MLND) and Zyngenia. 

    She also serves on the boards of the New England Venture Capital Association and BioHealth Innovation Management, and on the Advisory boards of Incubate Coalition and No Patient Left Behind. She was included on Fierce Biotech’s 2019 list of the Fiercest Women in Life Sciences and was selected three times as one of GrowthCap’s Top 40 Under 40 Growth Investors.

    Prior to joining NEA, Sara was an investing banking Associate with Merrill Lynch’s Global Healthcare Group, and previously, she worked as an investment banking Analyst at Morgan Stanley.

    Sara concurrently earned her MD (cum laude) and MBA from Yale University, where she was a Yale MBA Scholar. She received her AB (magna cum laude) in Biology from Harvard University.

November 19, 2020

  • Carolyn M. Clancy, MD, Deputy Under Secretary for Health for Discovery, Education and Affiliate Networks (DEAN), U.S. Department of Veterans’ Affairs

    Carolyn Clancy, M.D., MACP
    Assistant Under Secretary for Health, Discovery, Education & Affiliate Networks, Veterans Health Administration

    Dr. Clancy serves as the Assistant Under Secretary for Health (AUSH) for Discovery, Education & Affiliate Networks (DEAN), Veterans Health Administration (VHA), effective July 22, 2018. The Office of the DEAN fosters collaboration and knowledge transfer with facility-based educators, researchers and clinicians within VA, and between VA and its affiliates.

    Prior to her current position, she served as the VHA Executive in Charge, with the authority to perform the functions and duties of the Under Secretary for Health. As the Executive in Charge, Dr. Clancy directed a health care system with an annual budget of approximately $68 billion, overseeing the delivery of care to more than 9 million enrolled Veterans. Previously, she served as the Interim Under Secretary for Health from 2014-2015. Dr. Clancy also served as the VHA AUSH for Organizational Excellence, overseeing VHA’s performance, quality, safety, risk management, systems engineering, auditing, oversight, ethics and accreditation programs, as well as ten years as the Director, Agency for Healthcare Research and Quality.

    She is a highly experienced and nationally recognized physician executive. Dr. Clancy is a general internist and health services researcher, a graduate of Boston College and the University of Massachusetts Medical School. She holds an academic appointment at George Washington University’s School of Medicine and serves as Senior Associate Editor, Health Services Research Journal. She has contributed to eight academic text books and authored, co-authored and provided invited commentary in more than 225 scholarly journal articles. She served as member of the National Quality Forum’s Board of Directors, Chair of the AQA Alliance and served on the Board of Governors for the Patient-Centered Outcomes Research Institute. She is an elected member of the National Academy of Medicine and was presented with the 2014 Quality Champion Award from the National Committee for Quality Assurance. She was also named as an Honorary Fellow of the American Academy of Nursing and was selected as the 2015 Outstanding Federal Executive of the Year by Disabled American Veterans. In 2018, she was selected as one of the Top 50 Physician Executives by Modern Healthcare, and in 2019, she was identified as one of the 50 Most Influential Clinical Executives by Modern Healthcare.

    2018 – Present Assistant Under Secretary for Health, Discovery, Education & Affiliate Networks, Washington, DC
    2017 – 2018 Executive in Charge, Veterans Health Administration, Washington, DC
    2015 – 2017 Deputy Under Secretary for Health for Organizational Excellence, VHA, Washington, DC
    2015 Chief Medical Officer, VHA, Washington, DC
    2014 – 2015 Interim Under Secretary for Health, VHA, Washington, DC
    2013 – 2014 Assistant Deputy Under Secretary for Health for Quality, Safety & Value, Washington, DC
    2003 – 2013 Director, Agency for Healthcare Research and Quality (AHRQ), Washington, DC

    1984 Henry J. Kaiser Family Foundation Fellow in General Internal Medicine, University of Pennsylvania
    1982 Intern and Resident in Medicine, Worcester Memorial Hospital, Worcester, MA
    1979 Medical Doctor, University of Massachusetts School of Medicine, Amherst, MA
    1975 Bachelor of Science in Math and Chemistry, Boston College, Chestnut Hill, MA

December 3rd, 2020

  • Pamela Sutton-Wallace, MPH, Senior Vice President & Regional Chief Operating Officer, New York Presbyterian Hospital

    Pamela Sutton-Wallace is an accomplished and distinguished health care executive with more than 25 years of experience in various sectors of the health care industry.  Currently, Pam serves as Senior Vice President and Regional Chief Operating Officer at New York Presbyterian. In this capacity, she is responsible for strategic operations in the Brooklyn and Queens markets and oversees the NYP Physician Services division.

    Prior to her appointment at NYP, Pam served as the Chief Executive Officer for the University of Virginia (UVA) Medical Center in Charlottesville, Virginia from 2014-2020.  Overseeing a $2.2B budget, she strategically led UVA Health in receiving several national recognitions in quality, safety, patient experience and team member engagement.

    While at Duke University Hospital in Durham North Carolina for 17 years, Pam served in several leadership positions including: Senior Vice President for Hospital Operations, Chief Operating Officer for Ambulatory Services, Vice President for Perioperative Services and Chief of Staff to the Chancellor for Health Affairs. Pam has also held positions in the pharmaceutical and insurance industries at Pfizer and Blue Cross & Blue Shield of North Carolina, respectively.

    She received her undergraduate degree in Political Science and African-American Studies from Washington University in St. Louis, MO.  She later graduated from Yale University with a Master of Public Health (MPH) degree, completing her thesis with distinction. 

    Pam has served on several professional and community boards including the Duke University School of Nursing Board of Visitors, America’s Essential Hospitals, American Hospital Association Region 3 Policy Board, Virginia Hospital and Healthcare Association, Charlottesville Regional Chamber of Commerce and the Charlottesville Area Community Foundation (CACF) to name a few. With her 27 years of healthcare experience at some of the world's most renowned health systems, Ms. Sutton-Wallace brings valuable expertise and perspective to J2 Global's Board.

February 11, 2021

  • Prathiba Varkey, MBBS, MPH, MHPE, MBA, President and CEO, Northeast Medical Group Senior Vice President, Yale New Haven Health

    Prathibha Varkey, MBBS, MPH, MHPE, MBA, MA (privatim)
    President and Chief Executive Officer, Yale New Haven Health Northeast Medical Group
    Senior Vice President, Yale New Haven Health System
    Professor of Medicine, Yale School of Medicine
    Professor of Health Policy and Management, Yale School of Public Health


    Dr. Varkey serves as the Chief Executive Officer and President of the Yale New Haven Health Northeast Medical Group, and Senior Vice President of Yale New Haven Health System. Northeast Medical Group (NEMG) is the medical foundation of Yale New Haven Health and has approximately 2200 employees including over 1100 clinicians and operates 140 locations in Connecticut, New York and Rhode Island. Dr. Varkey is a Professor of Medicine at the Yale School of Medicine and Professor of Health Policy and Management, Yale School of Public Health.

    Prior to her current role, Dr. Varkey served as the President and Chief Executive Officer of the Seton Clinical Enterprise, a large multispecialty group (over 1500 employees) at Seton Family Healthcare, Austin, Texas and as Chief of Internal Medicine during her tenure at Seton. A nationally recognized expert in Quality Improvement, Dr. Varkey served as the President of the American College of Medical Quality between 2015 and 2017. She currently serves on the Lawrence and Memorial Hospital Board, the Central CT Coast YMCA Board and the University of New Haven Board of Trustees. She has previously served on the boards of the Christian Medical College Foundation, Physician One Urgent Care Centers, and the American College of Medical Quality. She is the editor of two books: Medical Quality Management (third edition published 2020) and Mayo Clinic Board review on Preventive Medicine and Public Health.

    Earlier in her career, Dr. Varkey served in a number of leadership positions at Mayo Clinic Rochester, including as Associate Chair of the Department of Medicine; medical director of Ask Mayo Clinic (national nurse triage line with 1.5 million covered lives); medical director of the Value Program at the Mayo Clinic Center for the Science of healthcare delivery; medical director of “Better” a mobile app start up jointly funded by Mayo Clinic and a venture capital firm; co-vice chair for the Outpatient Practice Committee; program director of the Preventive Medicine Fellowship, and as Director of the Quality Improvement Curriculum at Mayo Medical School, Mayo School of Graduate Medical Education and Mayo School of Continuing Medical Education. Dr. Varkey continues to be a Professor of Medicine and Professor of Preventive Medicine at Mayo Clinic in adjunct status.

    Dr. Varkey is the recipient of many awards including the American Medical Association Foundation Physician Leadership award, the ACGME Parker Palmer Courage to Teach award, the American College of Medical Quality President’s award, the Mayo Clinic individual excellence award, the American Medical Women’s Association Exceptional Mentoring Award, the World Woman leadership congress visionary woman leadership award and the CT woman of influence Corporate Leader Award.

    Dr. Varkey earned her MBBS (MD equivalent) from the Christian Medical College, Vellore, India; a Masters of Public Health from the Harvard School of Public Health, Boston, Massachusetts; a Masters of Health Professions Education (MHPE) from the University of Illinois, Chicago; a Masters of Business Administration from the Carlson School of Management at the University of Minnesota; and an honorary Masters of Arts (privatim) from Yale University. She completed her Internal Medicine Residency at the Yale New Haven Health Hospital of Saint Raphael and Preventive Medicine fellowship at Mayo Clinic in Rochester, Minnesota.

February 25, 2021

  • Susan Chapman Moss, MPH (’99), Senior Vice President, Payer Contracting & System Planning, Mass General Brigham

    Sue Chapman Moss, MPH knows that patients deserve more from the healthcare industry – care delivered with expertise, empathy, and value.  Her career spans management consulting, hospital operations, strategic planning and managed care contracting.  Sue is the outgoing Senior Vice President of Payer Contracting and System Planning at Mass General Brigham where she has led payer contract negotiations, payer/provider strategic partnerships and business planning services for a top tier, integrated health system.  And in March 2021, she will be joining BAYADA Health Care as Senior Vice President and Managing Director of Payer Contracting and Strategic Partnerships for a $1.5B non-profit that delivers healthcare at home in 23 states and 6 countries.

    Her accomplishments range from management of $100M operations at academic medical centers, planning and financing of $800M capital funds for ambulatory growth strategy, and leadership of $10B payer negotiations for large hospital/physician network including value-based arrangements.  Sue teaches at Harvard Medical School and chairs the Board of Trustees at The Center for Medical Simulation.  She holds a Master’s Degree in Public Health from Yale University and serves as Fellow of The Health Management Academy.    

March 4, 2021

  • Rahul Rajkumar, MD (’04), JD (’06), Chief Operating Officer, Care Solutions at Optum

    Rahul Rajkumar, MD, JD, FACP

    Rahul Rajkumar, MD, JD, FACP joined Optum in October, 2020 as the Chief Operating Officer of Care Solutions and Health Services.

    Dr. Rajkumar is a national leader in health care payment and delivery system reform that aims to improve health outcomes and quality, access and affordability, and health equity.  He has been a national leader in reengineering how we pay for health care – and reimagining how we delivery care. 

    As Senior Vice President and Chief Medical Officer of Blue Cross and Blue Shield of North Carolina (Blue Cross NC), Dr. Rajkumar led a staff of over 1,200, annual budget of $227 million, and provided direct oversight of payment  innovation design and strategy, customer group consulting, medical expense management, care management, network provider contracting, provider quality performance, medical and reimbursement policy, and pharmacy for the health plan that covers 3.9 million members in North Carolina.    

    During his tenure at Blue Cross NC, Dr. Rajkumar led the enterprise to implement Blue Premier, the most rapid and comprehensive shifts to value-based care in the nation by any health plan. Under his leadership, the plan achieved the milestone of more than 50 percent of eligible members served by a provider in a value-based, shared-risk agreement which included providers from nine of the largest health systems in the state, nearly half of the state’s independent primary care practices, and innovative advanced primary care practices.  In its first year, the program generated over $150 million in cost savings, quality improvements, and slowdown of the rate of spending. Dr. Rajkumar also led BCNC to achieve a 4 star rating in Medicare Advantage, launched an initiative to bring co-branded advanced primary care clinics to North Carolina with Iora Health, CityBlock, and CareMore, and rebuild the behavioral health care network to provide enhanced access and quality. 

    During the COVID-19 pandemic, Dr. Rajkumar demonstrated the plan’s strong, trusted partnership with providers across the state.  Through the Accelerate to Value program, Blue Cross NC provided revenue stabilization for over 530 independent practices and bridged these providers to enter Blue Premier, ensuring a more sustainable financial future and departure from traditional fee for service reimbursement. Blue Cross NC was also among the first health plans in the nation to pay for telehealth at parity, engaging and coaching over 1,000 providers weekly through new communications channel to adopt telehealth, and created a new supply chain for N95 masks sourced completely in North Carolina to prevent acute PPE shortages for providers in the state. 

    Prior to joining Blue Cross NC, Dr. Rajkumar was Senior Vice President and Chief Medical Office at CareFirst Blue Cross BlueShield, a multistate Blue Cross plan that serves members in Maryland, Virginia and the District of Columbia. At CareFirst, he led efforts to reduce medical costs and improve patient care. 

    Prior to CareFirst, Dr. Rajkumar served as Deputy Director at the CMS Innovation Center (CMMI), leading Medicare and Medicaid’s transition to new value-based payment models and a staff of over 400 and annual budget of over $1B.  During his tenure at CMMI, he led the development of pioneering programs to promote Accountable Care Organizations (ACOs), bolster primary care, implement bundled payments and increase patient safety.   Cumulatively, these programs shifted 30% of all Medicare payments into value-based models and contributed to an unprecedented slowing of per capita Medicare cost growth from 2012-2016.

    As an attending physician in the Department of Internal Medicine at Duke University Hospital, and Instructor at Harvard Medical School, he was responsible for patient care on an academic inpatient service, supervision and teaching of residents, interns and medical students. 

    Dr. Rajkumar earned his MD from the Yale University School of Medicine, a JD from Yale College of Law.  He completed his residency at Harvard Medical School/Brigham and Women’s Hospital and is board-certified in Internal Medicine.

March 11, 2021

  • Richard D’Aquila, MPH (’79), Managing Director, Destination Health Systems (Former President, Yale New Haven Health System and Yale New Haven Hospital)

    Richard D’Aquila is the Founder and Managing Director of Destination Health Systems. Destination Health Systems was launched in October 2020, and is a specialized healthcare consulting practice focused on academic medical centers and accelerated integration strategies for academic health systems.

    From 2006 to 2020, Rick was the President of Yale New Haven Hospital and Yale New Haven Health System in Connecticut. He was responsible for day-to-day operations of Yale New Haven Hospital, with an operating budget of $3.7 billion, and over 15,000 employees and 4,500 medical staff members. In October 2016, he assumed responsibility for system-wide ambulatory and service line strategies, as well as medical staff and nursing integration across the health system.

    From 2000 to 2006, Rick served as Senior Vice President and Chief Operating Officer of New York Presbyterian Hospital/Weill Cornell Medical Center. He also served in executive positions at St. Vincent’s Medical Center in Bridgeport, Connecticut, The Mount Sinai Hospital in Hartford, Connecticut, and Health Initiatives Corporation in Providence, Rhode Island. 

    Rick received his graduate degree in hospital administration from the Yale University School of Medicine and his bachelor’s degree in economics from Central Connecticut State University.  He is a member of lecturing faculty at Yale University School of Medicine’s Department of Epidemiology and Public Health and Yale School of Management.

    Highlights From Yale New Haven Hospital and Yale New Haven Health System Career

    • Integrated the Hospital of Saint Raphael into Yale New Haven Hospital operations, making it one of the top 10 largest hospitals in the United States with 1,541 licensed beds and 55 outpatient centers across Connecticut.
    • Developed and implemented a vision to establish Yale New Haven Hospital as a regionally preeminent destination hospital. Vision components include:
      • Becoming a high reliability organization and implementing a culture of safety and transparency
      • Establishing leading specialty clinical programs
      • Developing a statewide physician network
      • Providing a superior patient experience
      • Defining and implementing employer of choice strategies
      • Implementing cutting edge technology including Epic
      • Providing efficient and cost effective operations
    • Implemented a service line organizational structure aligned with the medical center’s destination hospital vision. The seven service lines are:
      • Children’s Hospital
      • Smilow Cancer Hospital
      • Heart and Vascular
      • Neurosciences
      • Transplant
      • Musculoskeletal
      • Digestive Health
    • Developed the first ambulatory strategic plan for the health system in collaboration with Yale School of Medicine.
    • Integrated medical staff and nursing administration functions across the health system
    • Developed and led a comprehensive cost and value positioning initiative across the health system, with an emphasis on clinical redesign (care delivery transformation) and physician engagement.  
    • Achieved 13 years of unprecedented growth and financial performance for both the Hospital and its Medical School partner, Yale School of Medicine.
    • Assembled a top performing leadership team with a distinguished track record of superior operating performance, strategic agility and effective execution.